Free Trial
NASDAQ:AVR

Anteris Technologies Global (AVR) Stock Price, News & Analysis

Anteris Technologies Global logo
$4.36 -0.15 (-3.33%)
As of 05/30/2025 04:00 PM Eastern

About Anteris Technologies Global Stock (NASDAQ:AVR)

Key Stats

Today's Range
$4.09
$4.50
50-Day Range
$2.47
$5.51
52-Week Range
$2.34
$8.79
Volume
156,673 shs
Average Volume
205,328 shs
Market Capitalization
$157.23 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.50
Consensus Rating
Buy

Company Overview

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

Receive AVR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Anteris Technologies Global and its competitors with MarketBeat's FREE daily newsletter.

AVR Stock News Headlines

"I'm risking my reputation on this"
Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.
Anteris Technologies Global Inc (AVR)
Anteris Reports One-Year Patient Outcomes for DurAVR® THV
Lake Street Remains a Buy on Anteris Technologies Global Corp. (AVR)
See More Headlines

AVR Stock Analysis - Frequently Asked Questions

Anteris Technologies Global's stock was trading at $5.58 at the beginning of 2025. Since then, AVR stock has decreased by 21.9% and is now trading at $4.36.
View the best growth stocks for 2025 here
.

Anteris Technologies Global Corp (NASDAQ:AVR) released its earnings results on Tuesday, May, 13th. The company reported ($0.61) EPS for the quarter.

Anteris Technologies Global (AVR) raised $89 million in an IPO on Friday, December 13th 2024. The company issued 14,800,000 shares at $6.00 per share.

Anteris Technologies Global's lock-up period expires on Wednesday, June 11th. Anteris Technologies Global had issued 14,800,000 shares in its initial public offering on December 13th. The total size of the offering was $88,800,000 based on an initial share price of $6.00. Shares of the company owned by company insiders and major shareholders will be eligible for trade following the expiration of the lock-up period.

Anteris Technologies Global's top institutional investors include L1 Capital Pty Ltd (19.10%), ADAR1 Capital Management LLC (4.65%), Nantahala Capital Management LLC (4.61%) and Regal Partners Ltd (2.49%).

Shares of AVR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/13/2025
Today
6/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:AVR
Previous Symbol
NASDAQ:AVR
Web
N/A
Fax
N/A
Employees
138
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$16.50
High Stock Price Target
$22.00
Low Stock Price Target
$9.00
Potential Upside/Downside
+278.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.71 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$157.23 million
Optionable
N/A
Beta
N/A
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:AVR) was last updated on 6/2/2025 by MarketBeat.com Staff
From Our Partners